Marta Peña

9PUBLICATIONS
63CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 12, 2026
Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study.

Marta Peña, Lorenzo Lazzari, Diego F Martínez

|Jan 13, 2026
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC study.

Marta Peña, Giulia Losi, Víctor Navarro

|Apr 02, 2025
Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC.

M Peña, D F Martinez, A Paviglianiti

|Mar 31, 2025
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Leyre Bento, Antonio Gutiérrez, Carmen Martínez

|Dec 14, 2024
Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomas.

Giulia Losi, Alberto Mussetti, Marta Peña

|Jun 04, 2024
Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study.

Lidia Hurtado, Melinda Gonzalez Concepcion, Aida Flix-Valle

Pageof 2

Frequent Collaborators

5 joint publications

Anna Sureda

4 joint publications

Alberto Mussetti

3 joint publications

Leyre Bento

2 joint publications

Fabio Ciceri